Oflas, M. Et Al. 2023. The efficacy of prognostic factors derived from Ga68-PSMA PET-CT images in predicting treatment response and survival in patients with metastatic castration-resistant prostate cancer treated with Lu-177PSMA. EANM’23 , (Vienna, Austria).

Oflas, M., Has Şimşek, D., Şanlı, Y., Kuyumcu, S., Işık, E. G., Karadoğan, S., ... Başaran, M.(2023). The efficacy of prognostic factors derived from Ga68-PSMA PET-CT images in predicting treatment response and survival in patients with metastatic castration-resistant prostate cancer treated with Lu-177PSMA . EANM’23, Vienna, Austria

Oflas, Melis Et Al. "The efficacy of prognostic factors derived from Ga68-PSMA PET-CT images in predicting treatment response and survival in patients with metastatic castration-resistant prostate cancer treated with Lu-177PSMA," EANM’23, Vienna, Austria, 2023

Oflas, Melis Et Al. "The efficacy of prognostic factors derived from Ga68-PSMA PET-CT images in predicting treatment response and survival in patients with metastatic castration-resistant prostate cancer treated with Lu-177PSMA." EANM’23 , Vienna, Austria, 2023

Oflas, M. Et Al. (2023) . "The efficacy of prognostic factors derived from Ga68-PSMA PET-CT images in predicting treatment response and survival in patients with metastatic castration-resistant prostate cancer treated with Lu-177PSMA." EANM’23 , Vienna, Austria.

@conferencepaper{conferencepaper, author={Melis OFLAS Et Al. }, title={The efficacy of prognostic factors derived from Ga68-PSMA PET-CT images in predicting treatment response and survival in patients with metastatic castration-resistant prostate cancer treated with Lu-177PSMA}, congress name={ EANM’23}, city={Vienna}, country={Austria}, year={2023}}